Clinical Research Directory
Browse clinical research sites, groups, and studies.
Comparison of Oral Ferrous Sulfate to Intravenous Ferumoxytol in Antepartum Iron Deficiency Anemia
Sponsor: Stanford University
Summary
Evaluate the extent to which treatment of iron deficiency anemia beyond 24-34 weeks' gestation of pregnancy with intravenous iron increases hemoglobin compared to oral iron. The investigators will test the hypothesis that pregnant women who are anemic in the second and third trimester are more likely to significantly increase their hemoglobin with intravenous iron as opposed to the usual standard of care, oral iron.
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
83
Start Date
2021-01-21
Completion Date
2024-07-01
Last Updated
2026-06-30
Healthy Volunteers
No
Conditions
Interventions
Ferumoxytol Injection [Feraheme]
510mg intravenous ferumoxytol
Ferrous Sulfate
325mg oral ferrous sulfate
Locations (1)
Stanford University School of Medicine/Lucile Packard Childrens Hospital
Stanford, California, United States